Article
Immunometabolism mRNA expression phenotypes and reprogramming of CD14 in T2DM with or without CVD.
International immunopharmacology - 1 Sept 2023
Bendaya Imen, Ben Jemaa Awatef, Sahraoui Ghada, Kharrat Maher, Sdiri Wissem, Oueslati Ridha
Abstract excerpt
BACKGROUND/AIM: Type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVD) have a significant impact on the expression of genes in peripheral blood mononuclear cells (PBMCs). The primary objective of this study was to investigate the role of two signaling pathways, STAT1/6, and two important modulators of immunometabolism, leptin and PPARs, in the development of T2DM with and without CVD. Furthermore, the...
Topics
Join the communities discussing this publication.
